「JCN Newswire」記事一覧
-
4試合の激闘がリヤド・シーズンを彩る 井上尚弥、「ナイト・オブ・ザ・サムライ」で世界王座防衛
JCN Newswire -
Taxinexo Advances Large-Scale Commercial Deployment of Level 4 Autonomous Vehicles Across the United States
JCN Newswire -
BCQ (01963.HK) to Pay RMB 585 Million Cash Dividend, Driving Share Price and Yield Upside
JCN Newswire -
Honda、2025年11月度 四輪車 生産・販売・輸出実績を発表
JCN Newswire -
トヨタ、2025年11月 販売・生産・輸出実績を発表
JCN Newswire -
KKR、フォーラムエンジニアリングに対する公開買付けを完了
JCN Newswire -
PAG、KKR及びサッポロホールディングス、サッポロ不動産開発の株式譲渡に関する契約締結を発表
JCN Newswire -
Avantor Appoints Gladys Wang as Vice President, Bioprocessing Commercial, Asia, Middle East & Africa
JCN Newswire -
MHIEC、台湾・台中市向けにごみ焼却発電施設の主要機器供給契約を締結
JCN Newswire -
THE HANEDA GODZILLA GLOBAL PROJECT OFFICIALLY KICKS OFF COMPLETION EVENT
JCN Newswire -
Holiverse Announces Development of Offline AI Device to Return Data Control to Users
JCN Newswire -
東北大学と富士通、「NanoTerasu」の測定データに因果発見AIを適用し、超伝導発現メカニズム解明に繋がる因果関係を自動抽出
JCN Newswire -
Sri Lanka and the Middle East's top real estate achievements recognised at 2025 PropertyGuru Asia Property Awards
JCN Newswire -
三菱重工グループ、デジタル人材育成を加速
JCN Newswire -
国内初、三菱重工とエクシオグループが二相式DLC方式のGPUサーバー構築・商用利用開始
JCN Newswire -
A New Benchmark for Specialized Technology Stocks in Hong Kong! CiDi's Listing Marks a New Chapter in Commercial Intelligent Driving
JCN Newswire -
Spritzer MerryLand Returns This Year-End, Bringing Magical Festive Cheer to Taiping
JCN Newswire -
1World Online and Culinary Heritage Announce Strategic Partnership and Joint Launches in Europe
JCN Newswire -
キリンと富士通、創薬DX技術を活用し、AIと実試験でシチコリンの腸脳作用メカニズムを解明
JCN Newswire -
マツダ、「D&I AWARD」において最上位「ベストワークプレイス」に2年連続認定
JCN Newswire -
TASPEN Enhances Digital Pension Services with Mobile Biometric Authentication
JCN Newswire -
Developers and designers of tomorrow's cities triumph at the 20th PropertyGuru Asia Property Awards Grand Final
JCN Newswire -
ニュース視聴者の10人中7人が「国際ニュースはこれまで以上に重要」と回答
JCN Newswire -
CBL International Limited Achieves EcoVadis Silver Medal, Ranking Among Top 15% Globally for Sustainability Performance
JCN Newswire -
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
JCN Newswire -
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
JCN Newswire -
Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares
JCN Newswire -
韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ
JCN Newswire -
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
JCN Newswire -
2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
JCN Newswire
